{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T11:13:44Z","timestamp":1780485224705,"version":"3.54.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","jpedhc.org","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pediatric Health Care"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.pedhc.2017.10.002","type":"journal-article","created":{"date-parts":[[2018,2,15]],"date-time":"2018-02-15T02:10:43Z","timestamp":1518660643000},"page":"S2-S12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Pathophysiology and Management of Mild to Moderate Pediatric Atopic Dermatitis"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4354-4265","authenticated-orcid":false,"given":"Kammi Yap","family":"Sayaseng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peggy","family":"Vernon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pedhc.2017.10.002_bib1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/ajd.12015","article-title":"Use of bleach baths for the treatment of infected atopic eczema","volume":"54","author":"Barnes","year":"2013","journal-title":"Australasian Journal of Dermatology"},{"key":"10.1016\/j.pedhc.2017.10.002_bib2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1034\/j.1600-0625.2000.009003165.x","article-title":"The 500 Dalton rule for the skin penetration of chemical compounds and drugs","volume":"9","author":"Bos","year":"2000","journal-title":"Experimental Dermatology"},{"key":"10.1016\/j.pedhc.2017.10.002_bib3","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s40272-013-0013-9","article-title":"Topical calcineurin inhibitors for atopic dermatitis: review and treatment recommendations","volume":"15","author":"Carr","year":"2013","journal-title":"Paediatric Drugs"},{"key":"10.1016\/j.pedhc.2017.10.002_bib4","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1001\/archpedi.159.8.745","article-title":"The price of pruritus: sleep disturbance and cosleeping in atopic dermatitis","volume":"159","author":"Chamlin","year":"2005","journal-title":"Archives of Pediatrics and Adolescent Medicine"},{"key":"10.1016\/j.pedhc.2017.10.002_bib5","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jaci.2016.06.002","article-title":"Multifactorial skin barrier deficiency and atopic dermatitis: Essential topics to prevent the atopic march","volume":"138","author":"Egawa","year":"2016","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"4S","key":"10.1016\/j.pedhc.2017.10.002_bib6","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/j.jaci.2017.01.009","article-title":"Current guidelines for the evaluation and management of atopic dermatitis: A comparison of the Joint Task Force Practice Parameter and American Academy of Dermatology guidelines","volume":"139","author":"Eichenfield","year":"2017","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.pedhc.2017.10.002_bib7","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1542\/peds.2014-3678","article-title":"Translating atopic dermatitis management guidelines into practice for primary care providers","volume":"136","author":"Eichenfield","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.pedhc.2017.10.002_bib8","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.jaad.2017.06.010","article-title":"Long-term safety of crisaborole ointment 2% in children and adults with mild to moderate atopic dermatitis","volume":"77","author":"Eichenfield","year":"2017","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"5 Suppl.","key":"10.1016\/j.pedhc.2017.10.002_bib9","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.12788\/j.sder.2016.043","article-title":"Assessing the new and emerging treatments for atopic dermatitis","volume":"35","author":"Eichenfield","year":"2016","journal-title":"Seminars in Cutaneous Medicine and Surgery"},{"key":"10.1016\/j.pedhc.2017.10.002_bib10","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaad.2014.03.023","article-title":"Guidelines of care for the management of atopic dermatitis: Section 2. Management and treatment of atopic dermatitis with topical therapies","volume":"71","author":"Eichenfield","year":"2014","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1016\/j.pedhc.2017.10.002_bib11","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jaad.2013.10.010","article-title":"Guidelines of care for the management of atopic dermatitis: Section 1. Diagnosis and assessment of atopic dermatitis","volume":"70","author":"Eichenfield","year":"2014","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"5 Suppl.","key":"10.1016\/j.pedhc.2017.10.002_bib12","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.12788\/j.sder.2016.044","article-title":"The changing paradigm of atopic dermatitis therapy","volume":"35","author":"Friedlander","year":"2016","journal-title":"Seminars in Cutaneous Medicine and Surgery"},{"issue":"1","key":"10.1016\/j.pedhc.2017.10.002_bib13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/1523-1747.ep12297888","article-title":"Type 4 phosphodiesterase inhibitors have clinical and in\u00a0vitro anti-inflammatory effects in atopic dermatitis","volume":"107","author":"Hanifin","year":"1996","journal-title":"Journal of Investigative Dermatology"},{"key":"10.1016\/j.pedhc.2017.10.002_bib14","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/JDN.0b013e3181970df1","article-title":"A practical management of atopic dermatitis-palliative care to contact dermatitis","volume":"1","author":"Hanna","year":"2009","journal-title":"Journal of the Dermatology Nurses\u2019 Association"},{"issue":"4","key":"10.1016\/j.pedhc.2017.10.002_bib15","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1038\/cti.2013.1","article-title":"Maternal and infant infections stimulate a rapid leukocyte response in breastmilk","volume":"2","author":"Hassiotou","year":"2013","journal-title":"Clinical & Translational Immunology"},{"issue":"5","key":"10.1016\/j.pedhc.2017.10.002_bib16","doi-asserted-by":"crossref","first-page":"e808","DOI":"10.1542\/peds.2008-2217","article-title":"Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity","volume":"123","author":"Huang","year":"2009","journal-title":"Pediatrics"},{"issue":"5 Suppl.","key":"10.1016\/j.pedhc.2017.10.002_bib17","first-page":"S89","article-title":"Review of critical issues in the pathogenesis of atopic dermatitis","volume":"35","author":"Irvine","year":"2016","journal-title":"Seminars in Cutaneous Medicine and Surgery"},{"issue":"4","key":"10.1016\/j.pedhc.2017.10.002_bib18","first-page":"390","article-title":"Crisaborole topical ointment, 2%: A nonsteroidal, topical, anti-inflammatory phosphodiesterase 4 inhibitor in clinical development for the treatment of atopic dermatitis","volume":"15","author":"Jarnagin","year":"2016","journal-title":"Journal of Drugs in Dermatology"},{"issue":"2","key":"10.1016\/j.pedhc.2017.10.002_bib19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5487\/TR.2015.31.2.089","article-title":"Influences of environmental chemicals on atopic dermatitis","volume":"31","author":"Kim","year":"2015","journal-title":"Toxicology Research"},{"issue":"7624","key":"10.1016\/j.pedhc.2017.10.002_bib20","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1136\/bmj.39304.464016.AE","article-title":"Effect of prolonged and exclusive breast feeding on risk of allergy and asthma: Cluster randomised trial","volume":"335","author":"Kramer","year":"2007","journal-title":"British Medical Journal"},{"key":"10.1016\/j.pedhc.2017.10.002_bib21","series-title":"Protopic\u00ae (tacrolimus) ointment, 0.03% and 0.1%: Product Monograph [Monograph]","year":"2016"},{"issue":"5","key":"10.1016\/j.pedhc.2017.10.002_bib22","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1172\/JCI21060","article-title":"New insights into atopic dermatitis","volume":"113","author":"Leung","year":"2004","journal-title":"Journal of Clinical Investigation"},{"issue":"3 Pt. 1","key":"10.1016\/j.pedhc.2017.10.002_bib23","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0190-9622(94)70213-6","article-title":"Atopic dermatitis: Triggering factors","volume":"31","author":"Morren","year":"1994","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"3","key":"10.1016\/j.pedhc.2017.10.002_bib24","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jaad.2016.05.046","article-title":"Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults","volume":"75","author":"Paller","year":"2016","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"Suppl. 1","key":"10.1016\/j.pedhc.2017.10.002_bib25","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1542\/peds.2006-0900CC","article-title":"Effects of probiotics on atopic dermatitis: A randomised controlled trial","volume":"118","author":"Perry","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.pedhc.2017.10.002_bib26","series-title":"Eucrisa\u2122 (crisaborole) ointment, 2%: Highlights of prescribing information","year":"2016"},{"issue":"1","key":"10.1016\/j.pedhc.2017.10.002_bib27","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/pde.12698","article-title":"Quality of life in families with children with atopic dermatitis","volume":"33","author":"Pusti\u0161ek","year":"2016","journal-title":"Pediatric Dermatology"},{"key":"10.1016\/j.pedhc.2017.10.002_bib28","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3389\/fmicb.2016.00507","article-title":"Probiotics and atopic dermatitis: An overview","volume":"7","author":"Rather","year":"2016","journal-title":"Frontiers in Microbiology"},{"issue":"3","key":"10.1016\/j.pedhc.2017.10.002_bib29","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2165\/00002018-200831030-00001","article-title":"The US FDA \u2018black box\u2019 warning for topical calcineurin inhibitors: An ongoing controversy","volume":"31","author":"Ring","year":"2008","journal-title":"Drug Safety"},{"issue":"1","key":"10.1016\/j.pedhc.2017.10.002_bib30","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/jid.2010.251","article-title":"Eczema prevalence in the United States: Data from the 2003 National Survey of Children's Health","volume":"131","author":"Shaw","year":"2011","journal-title":"Journal of Investigative Dermatology"},{"key":"10.1016\/j.pedhc.2017.10.002_bib31","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jaad.2014.03.030","article-title":"Guidelines of care for the management of atopic dermatitis: Section 3. Management and treatment with phototherapy and systemic agents","volume":"71","author":"Sidbury","year":"2014","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1016\/j.pedhc.2017.10.002_bib32","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.jaad.2014.08.038","article-title":"Guidelines of care for the management of atopic dermatitis: Section 4. Prevention of disease flares and use of adjunctive therapies and approaches","volume":"71","author":"Sidbury","year":"2014","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10.1016\/j.pedhc.2017.10.002_bib33","doi-asserted-by":"crossref","first-page":"884","DOI":"10.3390\/jcm4050884","article-title":"Diagnosis of atopic dermatitis: Mimics, overlaps, and complications","volume":"4","author":"Siegfried","year":"2015","journal-title":"Journal of Clinical Medicine"},{"issue":"7","key":"10.1016\/j.pedhc.2017.10.002_bib34","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1038\/jid.2013.19","article-title":"Climatic factors are associated with childhood eczema prevalence in the United States","volume":"133","author":"Silverberg","year":"2013","journal-title":"Journal of Investigative Dermatology"},{"key":"10.1016\/j.pedhc.2017.10.002_bib35","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.det.2017.02.008","article-title":"Special considerations for therapy of pediatric atopic dermatitis","volume":"35","author":"Silverberg","year":"2017","journal-title":"Dermatologic Clinics"},{"issue":"3","key":"10.1016\/j.pedhc.2017.10.002_bib36","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jaad.2015.10.043","article-title":"Patient burden of moderate to severe atopic dermatitis (AD): Insights from a phase 2b clinical trial of dupilumab in adults","volume":"74","author":"Simpson","year":"2016","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"5 Suppl.","key":"10.1016\/j.pedhc.2017.10.002_bib37","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.12788\/j.sder.2016.041","article-title":"Update on epidemiology, diagnosis, and disease course of atopic dermatitis","volume":"35","author":"Simpson","year":"2016","journal-title":"Seminars in Cutaneous Medical Surgery"},{"issue":"14","key":"10.1016\/j.pedhc.2017.10.002_bib38","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1001\/jama.2016.1459","article-title":"Management of atopic dermatitis","volume":"315","author":"Stein","year":"2016","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.pedhc.2017.10.002_bib39","series-title":"Elidel\u00ae (pimecrolumus) Cream, 1%: Highlights of Prescribing Information","year":"2017"},{"key":"10.1016\/j.pedhc.2017.10.002_bib40","first-page":"CD012119","article-title":"Emollients and moisturisers for eczema","volume":"2","author":"van Zuuren","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1016\/j.pedhc.2017.10.002_bib41","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1111\/j.1365-2133.2009.09412.x","article-title":"Predicting risk for early infantile atopic dermatitis by hereditary and environmental factors","volume":"161","author":"Wen","year":"2009","journal-title":"British Journal of Dermatology"},{"issue":"9","key":"10.1016\/j.pedhc.2017.10.002_bib42","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1136\/adc.2004.060673","article-title":"Effects of probiotics on atopic dermatitis: A randomised controlled trial","volume":"90","author":"Weston","year":"2005","journal-title":"Archives of Disease in Childhood"},{"issue":"1","key":"10.1016\/j.pedhc.2017.10.002_bib43","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jaci.2006.02.031","article-title":"Patient perspectives on the management of atopic dermatitis","volume":"118","author":"Zuberbier","year":"2006","journal-title":"Journal of Allergy and Clinical Immunology"}],"container-title":["Journal of Pediatric Health Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891524517303577?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891524517303577?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T22:25:55Z","timestamp":1535063155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891524517303577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0891524517303577"],"URL":"https:\/\/doi.org\/10.1016\/j.pedhc.2017.10.002","relation":{},"ISSN":["0891-5245"],"issn-type":[{"value":"0891-5245","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathophysiology and Management of Mild to Moderate Pediatric Atopic Dermatitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Pediatric Health Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pedhc.2017.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.pedhc.2017.10.003","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the National Association of Pediatric Nurse Practitioners. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}